University of Alabama at Birmingham
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Alabama at Birmingham sits in the top decile of US sponsors by registered trial count (#26 of 15,742 sponsors by registered trial count).
University of Alabama at Birmingham: 1,160 sponsored US clinical trials, 216 recruiting.
University of Alabama at Birmingham sponsors 1,160 registered US clinical trials on ClinicalTrials.gov, 216 of them currently recruiting, and 723 completed. 97 of these trials are in Phase 3-4 (later-stage) and 259 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 15 trials.
Top-decile sponsor footprint
University of Alabama at Birmingham ranks in the top decile of sponsors by registered trial count (#26 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
723 of 812 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (89.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,160 total, page 14 of 24
Cognitive Aspects of Response to Treatment for Weight-related Health to Improve Eating and Exercise Earlier in Life
NCT03329300
Magic Camp for Children With Hemiplegic Cerebral Palsy
NCT03620279
Telemedicine in Spina Bifida Transition: A Pilot Study
NCT03466996
ACES - ACE Inhibitors Combined With Exercise for Seniors With Hypertension
NCT03295734
Bladder Antimuscarinic Medication and Accidental Bowel Leakage
NCT03543566
Outpatient Foley For Starting Induction of Labor at Term in Nulliparous Women
NCT03472937
Nicotine Replacement Therapy (NRT) Sampling and Selection to Increase Medication Adherence
NCT03276780
Pilot Trial of Microsphere Oxycodone (Xtampza ER) for Pain Management in Patients Receiving Radiotherapy for Locally Advanced Head and Neck Cancer
NCT03317730
FET-PET/MRI for Surgical Assessment of Pediatric Brain Tumors
NCT03451123
Scale Up Evaluation of a Physical Activity Program for Adults With Physical Disability
NCT03024320
A Resilience Building Intervention to Promote Successful Aging
NCT03294655
Prematurity Related Ventilatory Control (PRE-VENT) - Specific Aim 2
NCT03333161
Prematurity Related Ventilatory Control (PRE-VENT) - Specific Aim 3
NCT03333174
Oxalobacter Formigenes Colonization and Urinary Oxalate Excretion
NCT03752684
Quadratus Lumborum Block Versus Control for Total Hip Arthroplasty
NCT03408483
A Study for Testing Text Messaging and Newsletter as a Strategy for Interrupting Sedentary Behavior
NCT03671499
Skeletal Health in Bariatric Surgery Patients
NCT03331536
Monoclonal Antibody-Based Sequential Therapy for Deep Remission in Multiple Myeloma
NCT03224507
Pilot and Feasibility Trial of a Telehealth Dietary Intervention for MS
NCT03372187
Effect of tDCS Montage on Measures of Appetite
NCT03396549
A Novel Regimen to Prevent Malaria and STI in Pregnant Women With HIV
NCT03431168
CONfident Treatment Decisions in Living With Rheumatoid Arthritis
NCT03317756
Optimal Timing of Percutaneous Intervention in Non-maturing Dialysis Fistulas
NCT03245944
Effects of Individual Intervention for Men in Focused Deterrence Program
NCT03184116
Tele-Exercise and Multiple Sclerosis
NCT03117881
Unlocking Dystonia From Parkinson's Disease With Directional DBS Technology
NCT03409120
Phase II Study of Binimetinib in Children and Adults With NF1 Plexiform Neurofibromas
NCT03231306
The Myeloma Pack: A Multi-Modality Educational Intervention Strategy to Engage Patients With Multiple Myeloma
NCT03777306
Use of the Modified Beef Tongue Model for Teaching Repair of Obstetrical Fourth-Degree Laceration to Residents
NCT03341351
Closed Eye Neutrophils in Dry Eye Disease
NCT03332342
Pretreatment Staging of High-Risk Prostate Cancer With 18F-Fluciclovine PET/MRI
NCT03264456
Alcohol Research Consortium in HIV-Intervention Research Arm
NCT02938377
Biomarkers to Guide Directional DBS for Parkinson's Disease
NCT03353688
Spectacles Lens in Concussed Kids
NCT03123822
Hypoxic Changes in Hepatocellular Carcinoma (HCC) Following Trans Arterial Chemo Embolization and Stereotactic Radiation: Fluorine18 (18F) Fluoromisonidazole (FMISO) Imaging
NCT03303469
Topical Chemoprevention of Skin Cancer Biomarkers
NCT02636569
Examining Racial and SocioEconomic Disparities (ERASED) in Chronic Low Back Pain Study
NCT03338192
Folfirinox or Gemcitabine-Nab Paclitaxel Followed by Stereotactic Body Radiotherapy for Locally Advanced Pancreatic Cancer
NCT03600623
Mindfulness, Exercise and Nutrition To Optimize Resilience for Individuals With a Spinal Cord Injury.
NCT03207737
Biobanking of Rett Syndrome and Related Disorders
NCT02705677
Preventing Youth Soccer Injury
NCT04266925
Glyburide vs Placebo as Prophylaxis Against Cerebral Edema in Patients Receiving Radiosurgery for Brain Metastases (RAD 1502/UAB 1593)
NCT02460874
Diet and Exercise After Pancreatic Cancer
NCT03187028
Mid and Standard Frequency Ventilation in Infants With Respiratory Distress Syndrome
NCT03231735
Individualized Cognitive Training in HIV
NCT03122288
Olanzapine for the Treatment of Chronic Nausea and/or Vomiting in Advanced Cancer Patients
NCT03137121
Multimodal Exercise Training Poststroke
NCT03174392
Oral Probiotic Administration to Modulate the Airway Microbiome in Obese Asthmatic Subjects
NCT03157518
Enhancing Shared Decision-Making in Metastatic Breast Cancer (Qualitative Study)
NCT03248258
Understanding Value in Metastatic Breast Cancer
NCT03257917
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 129 |
| Phase 2 | 130 |
| Phase 3 | 25 |
| Phase 4 | 72 |
Therapeutic Areas
What is open in the University of Alabama at Birmingham pipeline
216 recruiting of 1,160 indexed (19% open); 723 completed (62%).
Phase mix: 97 late (III/IV) vs 259 early (I/II) (early-phase heavy).
Top condition: Obesity (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Alabama at Birmingham: open-pipeline peers nationwide
Peers matched on 1,160 registered trials and 19% open enrollment, not the therapeutic-area sidebar.
University of Alabama at Birmingham sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,160 trials (± recruiting share)
- NYU Langone Health · 1,164 trials · 17% recruiting
- Wake Forest University Health Sciences · 1,140 trials · 15% recruiting
- Emory University · 1,208 trials · 17% recruiting
- Northwestern University · 1,209 trials · 15% recruiting
Sponsors near 19% open enrollment (± trial volume)
- University of Minnesota · 19% recruiting · 966 trials
- Mclean Hospital · 19% recruiting · 140 trials
- Children's Hospital Medical Center, Cincinnati · 19% recruiting · 571 trials
- Arkansas Children's Hospital Research Institute · 19% recruiting · 97 trials
Related
What to do with this University of Alabama at Birmingham page
1,160 registered trials is a research-attention snapshot, not an endorsement of University of Alabama at Birmingham or any single study.
- 216 of University of Alabama at Birmingham's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition University of Alabama at Birmingham studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Alabama at Birmingham pipeline card: 1,160 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.